{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:51:14Z","timestamp":1792615874693,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.atherosclerosis.2019.11.025","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T02:26:41Z","timestamp":1574994401000},"page":"143-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Predicted pathogenic mutations in STAP1 are not associated with clinically defined familial hypercholesterolemia"],"prefix":"10.1016","volume":"292","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9647-0108","authenticated-orcid":false,"given":"Itziar","family":"Lamiquiz-Moneo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Alejandra","family":"Restrepo-C\u00f3rdoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Mateo-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Bea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"del Pino Alberiche-Ruano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Garc\u00eda-Pav\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Cenarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4087-8729","authenticated-orcid":false,"given":"Cesar","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7043-0952","authenticated-orcid":false,"given":"Fernando","family":"Civeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4991-7445","authenticated-orcid":false,"given":"Rosa Mar\u00eda","family":"S\u00e1nchez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2003.11.010","article-title":"International panel on management of familial hypercholesterolemia, guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia","volume":"173","author":"Civeira","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/ATVBAHA.108.179564","article-title":"The LDL receptor","volume":"29","author":"Goldstein","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib3","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/eurheartj\/ehw028","article-title":"Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217","volume":"37","author":"Benn","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib4","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1161\/01.ATV.13.10.1460","article-title":"Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations","volume":"13","author":"Kotze","year":"1993","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/aje\/kwh236","article-title":"Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review","volume":"160","author":"Austin","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.recesp.2016.10.012","article-title":"SAFEHEART investigators, attainment of LDL cholesterol treatment goals in children and adolescents with familial hypercholesterolemia. The SAFEHEART follow-up registry","volume":"70","author":"Saltijeral","year":"2017","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/01.ATV.20.4.1089","article-title":"Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred","volume":"20","author":"Hunt","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib8","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1210\/jc.2015-3874","article-title":"The p.Leu167del Mutation in APOE Gene Causes Autosomal Dominant Hypercholesterolemia by Down-regulation of LDL Receptor Expression in Hepatocytes","volume":"101","author":"Cenarro","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCRESAHA.115.304660","article-title":"Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia","volume":"115","author":"Fouchier","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2011.12.021","article-title":"Molecular characterization of familial hypercholesterolemia in Spain","volume":"221","author":"Palacios","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib11","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib12","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jacc.2017.08.009","article-title":"Genetically confirmed familial hypercholesterolemia in patients with acute coronary syndrome","volume":"70","author":"Amor-Salamanca","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ejhg.2015.100","article-title":"Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction","volume":"24","author":"Br\u00e6nne","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib14","first-page":"730","article-title":"[Lipid profile of the Spanish population: the DRECE (diet and risk of cardiovascular disease in Spain) study. DRECE study group]","volume":"113","author":"G\u00f3mez-Gerique","year":"1999","journal-title":"Med. Cl\u00ednica"},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046688","article-title":"Predicting the functional effect of amino acid substitutions and indels","volume":"7","author":"Choi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004962","article-title":"PredictSNP2: a unified platform for accurately evaluating SNP effects by exploiting the different characteristics of variants in distinct genomic regions","volume":"12","author":"Bendl","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An integrated map of genetic variation from 1,092 human genomes","volume":"491","author":"1000 Genomes Project Consortium","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Exome Aggregation Consortium, Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib20","article-title":"The Genome Aggregation Database Consortium, B.M. Neale, M.J. Daly, D.G. MacArthur, Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes","author":"Karczewski","year":"2019","journal-title":"Genomics"},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib21","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S2213-8587(17)30096-7","volume":"5","author":"Zewinger","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib22","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ajhg.2016.04.003","article-title":"Consideration of cosegregation in the pathogenicity classification of genomic variants","volume":"98","author":"Jarvik","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib23","series-title":"R Foundation for Statistical Computing; Vienna, Austria","author":"Team","year":"2014"},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cca.2018.10.014","article-title":"A rare STAP1 mutation incompletely associated with familial hypercholesterolemia","volume":"487","author":"Blanco-Vaca","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrg3031","article-title":"Exome sequencing as a tool for Mendelian disease gene discovery","volume":"12","author":"Bamshad","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.atherosclerosis.2018.06.009","article-title":"Unusual genetic variants associated with hypercholesterolemia in Argentina","volume":"277","author":"Corral","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosissup.2017.07.002","article-title":"Spectrum of mutations in Italian patients with familial hypercholesterolemia: new results from the LIPIGEN study","volume":"29","author":"Pirillo","year":"2017","journal-title":"Atherosclerosis Suppl."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib28","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Global Lipids Genetics Consortium, Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib29","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41588-019-0378-y","article-title":"Multi-ancestry genome-wide gene-smoking interaction study of 387,272 individuals identifies new loci associated with serum lipids","volume":"51","author":"Bentley","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s10038-019-0591-7","article-title":"Genome-wide association study of blood lipids in Indians confirms universality of established variants","volume":"64","author":"Bandesh","year":"2019","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S1474-4422(06)70578-6","article-title":"Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data","volume":"5","author":"Fung","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib32","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jmedgenet-2014-102405","article-title":"Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR\/APOB\/PCSK9 mutations","volume":"51","author":"Futema","year":"2014","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2261-14-108","article-title":"Cardiogenics consortium, Whole-exome sequencing in an extended family with myocardial infarction unmasks familial hypercholesterolemia","volume":"14","author":"Br\u00e6nne","year":"2014","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib34","doi-asserted-by":"crossref","first-page":"e0126706","DOI":"10.1371\/journal.pone.0126706","article-title":"Genetic testing of Korean familial hypercholesterolemia using whole-exome sequencing","volume":"10","author":"Han","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib35","doi-asserted-by":"crossref","first-page":"36823","DOI":"10.1038\/srep36823","article-title":"The use of targeted exome sequencing in genetic diagnosis of young patients with severe hypercholesterolemia","volume":"6","author":"Jiang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib36","first-page":"1316","article-title":"Whole-gene duplication of PCSK9 as a novel genetic mechanism for severe familial hypercholesterolemia","volume":"34","author":"Iacocca","year":"2018","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2019.11.025_bib37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.recesp.2017.07.030","article-title":"Single nucleotide variants associated with polygenic hypercholesterolemia in families diagnosed clinically with familial hypercholesterolemia","volume":"71","author":"Lamiquiz-Moneo","year":"2018","journal-title":"Rev. Esp. Cardiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501931593X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501931593X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:41:33Z","timestamp":1758156093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501931593X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":37,"alternative-id":["S002191501931593X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.11.025","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicted pathogenic mutations in STAP1 are not associated with clinically defined familial hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}